Figure 4.

Kaplan–Meier database for cancer prognosis shows the survival probability of patients with cancer in retrospective studies with high and low decorin levels. We used KM plotter (175, 176) from Gene Expression Omnibus (GEO) and European Genome-Phenome Archive (EGA) repositories. There is a clear correlation between low decorin expression and lower survival rates for patients suffering from breast, uterine, lung, and hepatocellular carcinomas, which are some of the most common metastatic malignancies.